Drug target prediction through deep learning functional representation of gene signatures

Hao Chen(University of California, Riverside), Yingyao Zhou(Genomics Institute of the Novartis Research Foundation), John M. Joslin(Genomics Institute of the Novartis Research Foundation), Max W. Chang(University of California San Diego), Carter J. Canedy(Genomics Institute of the Novartis Research Foundation), Bin Zhou(Southwest Jiaotong University), Frederick J. King(Genomics Institute of the Novartis Research Foundation), Christopher Benner(University of California San Diego), Julian L. Wong(Genomics Institute of the Novartis Research Foundation), Sumit K. Chanda(Scripps Research Institute), Yu Wang(Genomics Institute of the Novartis Research Foundation), Yong Jia(Genomics Institute of the Novartis Research Foundation), Yang Zhong(Genomics Institute of the Novartis Research Foundation), Tao Jiang(Xuzhou Medical College), Joel Hayashi(Genomics Institute of the Novartis Research Foundation), Lars Pache(Sanford Burnham Prebys Medical Discovery Institute)
Nature Communications
February 29, 2024
10.1038/s41467-024-46089-y
Cited by 77

Related Papers

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
|Nature|2020|856
Host Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies
|PLoS Pathogens|2009|442
NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug–target interactions
|Bioinformatics|2018|380
The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression
|BMC Genomics|2014|310
MONN: A Multi-objective Neural Network for Predicting Compound-Protein Interactions and Affinities
|Cell Systems|2020|256